Gastrointestinal Cancer News

Increasing the age limit for routine genetic testing in patients with colorectal cancer could help identify more families affected by Lynch syndrome, the most common inherited colorectal cancer syndrome contributing to about 5% of all colon cancers, according to research shared at the annual conference of the European Society of Human Genetics.

Patients who have received organ transplants have a low rate of cancer screening adherence, according to a study published in the American Journal of Transplantation.

Today’s observance of World No Tobacco Day features the theme, “Tobacco — a threat to development.”

Michael A. Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center, took over this spring as president of American Association for Cancer Research.

Array BioPharma and Bristol-Myers Squibb entered a clinical collaboration to investigate two combinations as potential treatment for patients with metastatic colorectal cancer who have microsatellite stable tumors.

Researchers at the Center for Advanced Biomedical Imaging and Photonics at Beth Israel Deaconess Medical Center developed a novel tool designed to distinguish between benign pancreatic cysts and those that have the potential to transform into pancreatic cancer.

Brian Wolpin , MD, MPH, has been appointed director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute.

The FDA has announced several decisions and opinions related to hematology and oncology in the past month.

The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer.

Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting antiviral therapy compared with patients without HCC, according to results of a retrospective study.